Nice | Gatroesophageal Reflux Disease (GORD) in Children

25th May 2015 by Louise Hudman

Nice | Gatroesophageal Reflux Disease (GORD) in Children

This is a new guideline from Nice on the management of GORD in infants and children.

The main differences from common practice is that they advice that PPI or H2 antagonists are only used if other specific symptoms are present too (see below). Most children with isolated GORD need no treatment.

GORD in infants

Reassure parents that gastroesophageal reflux is a normal process. GORD (where it causes symptoms) is present in 40% of infants. Most therefore need no treatment and just reassurance that it will get better with time.

Join

Join to view the rest of this content, as well as access all the benefits of joining NASGP.

Join

Login

Already a member? Login to view this content.

Login

"I have found LocumDeck to be the most helpful and invaluable resource for keeping bookings and accounts. I want to thank you for the wonderful service you provide. Many thanks once again for all the NASGP provides, and particularly for use of the excellent resource LocumDeck has proved to be – something I have recommended to many colleagues who have taken a step to locum work."

Dr Ruth Snowball

Dr Ruth Snowball

See the full list of features within our NASGP membership plans

Membership